Literature DB >> 2331951

Fate of antacid gel in the stomach. Site of action and interaction with food.

P Bauerfeind1, T Cilluffo, D Armstrong, C Emde, W Müller-Duysing, P Duroux, A L Blum.   

Abstract

The site of action of a high-power Al-Mg antacid gel (buffering capacity 70 meq/10 ml) and its interaction with food was examined in 10 healthy volunteers. Combined pH-metries in antrum and corpus were performed in each volunteer on four occasions. In a randomized study design, antacid or placebo were given 1 hr after either a protein or a carbohydrate pancake, of which only the former had any acid-buffering capacity. Before the meal, pH was higher in the antrum than in the corpus (median antrum: 3.2, corpus 1.5). In the corpus, a protein pancake but not a carbohydrate pancake raised the pH (median pH after protein pancake: 3.5; after carbohydrate pancake: 1.4). In the antrum, the protein pancake had no effect, but the carbohydrate pancake decreased the pH (median pH after protein pancake: 3.1; after carbohydrate pancake: 2.0). The antacid had no effect in the corpus after either pancake. It raised intraluminal pH markedly in the antrum after a carbohydrate pancake (median antral pH before antacid: 2.0; after antacid: 3.3), whereas its effect in the antrum was weak after a protein pancake. In vitro experiments were conducted to explain the in vivo results: in contrast to a carbohydrate pancake, a protein pancake reduced the buffering capacity of the antacid by direct interaction. In conclusion, the effect of an antacid gel on intragastric pH is predominantly localized in the antrum and is attenuated in the presence of proteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331951     DOI: 10.1007/bf01540401

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  An invitro evaluation of commonly used antacids with special reference to aluminium hydroxide gel and dried aluminium hydroxide gel.

Authors:  J ARMSTRONG; M MARTIN
Journal:  J Pharm Pharmacol       Date:  1953-10       Impact factor: 3.765

2.  In vitro tests overestimate in vivo neutralizing capacity of antacids in presence of food.

Authors:  P Berchtold; W H Reinhart; U Niederhäuser; U Koller; F Halter
Journal:  Dig Dis Sci       Date:  1985-06       Impact factor: 3.199

3.  Antroduodenal motor response to solid-liquid and homogenized meals.

Authors:  W D Rees; V L Go; J R Malagelada
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

4.  In vivo and in vitro evaluation of liquid antacids.

Authors:  J S Fordtran; S G Morawski; C T Richardson
Journal:  N Engl J Med       Date:  1973-05-03       Impact factor: 91.245

Review 5.  Technical aspects of intraluminal pH-metry in man: current status and recommendations.

Authors:  C Emde; A Garner; A L Blum
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

6.  [Continuous intragastric pH-metry].

Authors:  P Bauerfeind; T Cilluffo; C J Fimmel; T Gasser; W Köhler; H Merki; C Emde; A Etienne; A L Blum
Journal:  Schweiz Med Wochenschr       Date:  1985-11-16

7.  Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects.

Authors:  C T Richardson; J H Walsh; M I Hicks; J S Fordtran
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

8.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

9.  [Antacids: A comparison of their in vitro neutralizing capacity in hydrochloric acid and in acidified peptone solution (author's transl)].

Authors:  C Walther; P Herzog; K H Hissnauer; H J Kühl; K H Holtermüller
Journal:  Z Gastroenterol       Date:  1982-05       Impact factor: 2.000

10.  Effect of food on antacid neutralizing capacity in man.

Authors:  F Halter; R Huber; W H Häcki; L Varga; C Bachmann
Journal:  Eur J Clin Invest       Date:  1982-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.